These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9884837)

  • 1. In vitro interaction of fluconazole and amphotericin B administered sequentially against Candida albicans: effect of concentration and exposure time.
    Ernst EJ; Klepser ME; Pfaller MA
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):205-10. PubMed ID: 9884837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.
    Lewis RE; Lund BC; Klepser ME; Ernst EJ; Pfaller MA
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1382-6. PubMed ID: 9624480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.
    Klepser ME; Wolfe EJ; Jones RN; Nightingale CH; Pfaller MA
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1392-5. PubMed ID: 9174207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
    Lignell A; Löwdin E; Cars O; Sjölin J
    J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans.
    Klepser ME; Wolfe EJ; Pfaller MA
    J Antimicrob Chemother; 1998 Mar; 41(3):397-401. PubMed ID: 9578168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
    Barchiesi F; Di Francesco LF; Compagnucci P; Arzeni D; Giacometti A; Scalise G
    J Antimicrob Chemother; 1998 Jan; 41(1):59-65. PubMed ID: 9511038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of fluconazole-amphotericin B antagonism to Candida albicans by agar diffusion.
    Scheven M; Senf L
    Mycoses; 1994; 37(5-6):205-7. PubMed ID: 7898518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative screening for fluconazole-amphotericin B antagonism in several Candida albicans strains by a comparative agar diffusion assay.
    Scheven M; Scheven C
    Mycoses; 1996; 39(3-4):111-4. PubMed ID: 8767003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans.
    Burgess DS; Hastings RW; Summers KK; Hardin TC; Rinaldi MG
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):13-8. PubMed ID: 10744363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
    Louie A; Kaw P; Banerjee P; Liu W; Chen G; Miller MH
    Antimicrob Agents Chemother; 2001 Feb; 45(2):485-94. PubMed ID: 11158745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-antifungal effect and adhesion to buccal epithelial cells of oral Candida dubliniensis isolates subsequent to limited exposure to amphotericin B, ketoconazole and fluconazole.
    Ellepola AN; Chandy R; Khan ZU
    J Investig Clin Dent; 2015 Aug; 6(3):186-92. PubMed ID: 24850753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
    Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
    Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans.
    Khan MS; Malik A; Ahmad I
    Med Mycol; 2012 Jan; 50(1):33-42. PubMed ID: 21756200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
    Katragkou A; McCarthy M; Alexander EL; Antachopoulos C; Meletiadis J; Jabra-Rizk MA; Petraitis V; Roilides E; Walsh TJ
    J Antimicrob Chemother; 2015 Feb; 70(2):470-8. PubMed ID: 25288679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans.
    Hirasawa M; Takada K
    J Antimicrob Chemother; 2004 Feb; 53(2):225-9. PubMed ID: 14688042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
    Skrodeniene E; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.
    van Etten EW; van de Rhee NE; van Kampen KM; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2275-81. PubMed ID: 1804000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of polyene-azole antagonism in liquid cultures of Candida albicans using an automated turbidometric method.
    Samaranayake YH; Samaranayake LP; Yeung KW
    Chemotherapy; 2001; 47(4):279-91. PubMed ID: 11399865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibility of Candida albicans blood isolates to 3 antifungal drugs: retrospective study in Rio Grande do Sul, Brazil, 1999-2009].
    Mattei AS; Alves SH; Mario DA; Watte G; Severo CB; Guazzelli Lda S; Oliveira Fde M; Severo LC
    Rev Iberoam Micol; 2013; 30(4):243-7. PubMed ID: 23500157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.